Serum and urinary macrophage migration inhibitory factor (MIF) in primary Sjögren's syndrome

Joint Bone Spine. 2019 May;86(3):393-395. doi: 10.1016/j.jbspin.2018.07.001. Epub 2018 Jul 17.

¹ Rheumatology Research Group, Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Clayton, Victoria 3168, Australia; Department of Immunology and Pathology, Monash University, Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria 3004, Australia. Electronic address: [email protected].
² Rheumatology Research Group, Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Clayton, Victoria 3168, Australia; The Szalmuk Family Department of Medical Oncology, Cabrini Institute, Malvern, Victoria 3144, Australia.
³ Rheumatology Research Group, Centre for Inflammatory Diseases, Monash University School of Clinical Sciences at Monash Health, Clayton, Victoria 3168, Australia.
⁴ Rheumatology Department, The Queen Elizabeth Hospital, Discipline of Medicine, University of Adelaide, South Australia 5011, Australia.

No abstract available

Keywords: Biomarker; Macrophage migration inhibitory factor (MIF); Primary Sjögren's syndrome (pSS).

Publication types